{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:06:46Z","timestamp":1790341606958,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejpb.2024.114260","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T16:34:21Z","timestamp":1710261261000},"page":"114260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Comprehensive ocular and systemic pharmacokinetics of dexamethasone after subconjunctival and intravenous injections in rabbits"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-8709","authenticated-orcid":false,"given":"Annika","family":"Valtari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8665-0659","authenticated-orcid":false,"given":"Susanna","family":"Posio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Toropainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5225-6866","authenticated-orcid":false,"given":"Anusha","family":"Balla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-345X","authenticated-orcid":false,"given":"Jooseppi","family":"Puranen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-9851","authenticated-orcid":false,"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Ranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati-Sisko","family":"Vellonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M. del","family":"Amo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114260_b0005","series-title":"\u201cOcular pharmacokinetics\u201d, in Pharmacology of the eye","first-page":"19","author":"Maurice","year":"1984"},{"issue":"3\u20134","key":"10.1016\/j.ejpb.2024.114260_b0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems. a shift to the posterior segment","volume":"13","author":"del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2024.114260_b0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2024.114260_b0020","author":"Hopkins","year":"2007","journal-title":"Ophthalmic Drugs: Diagnostic and Therapeutic Uses."},{"key":"10.1016\/j.ejpb.2024.114260_b0025","doi-asserted-by":"crossref","unstructured":"S. Neervannan, \u201cIntroduction and History of Ophthalmic Product Development,\u201d in AAPS advances in the pharmaceutical sciences series, vol. 37, 2021, pp. 3\u201313. 10.1007\/978-3-030-76367-1_1.","DOI":"10.1007\/978-3-030-76367-1_1"},{"key":"10.1016\/j.ejpb.2024.114260_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105553","article-title":"Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits","volume":"155","author":"Fayyaz","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114260_b0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.xphs.2020.09.051","article-title":"Comprehensive Ocular and systemic Pharmacokinetics of brinzolamide in rabbits after Intracameral, topical, and intravenous administration","volume":"110","author":"Naageshwaran","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114260_b0040","doi-asserted-by":"crossref","first-page":"121515","DOI":"10.1016\/j.ijpharm.2022.121515","article-title":"Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: bioavailability comparison","volume":"615","author":"Naageshwaran","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114260_b0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/10807680152729257","article-title":"Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection","volume":"17","author":"Lee","year":"2001","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114260_b0050","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s10792-020-01391-8","article-title":"Sustained subconjunctival drug delivery systems: current trends and future perspectives","volume":"40","author":"Rafiei","year":"2020","journal-title":"Int. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114260_b0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2004.12.007","article-title":"Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation","volume":"60","author":"Hosoya","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114260_b0060","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"Hamalainen","year":"1997","journal-title":"Invest. Ophthalmol. vis. Sci."},{"key":"10.1016\/j.ejpb.2024.114260_b0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114260_b0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000108117","article-title":"Transport Barriers in transscleral drug delivery for retinal diseases","volume":"39","author":"Kim","year":"2007","journal-title":"Ophthalmic Res."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114260_b0075","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114260_b0080","first-page":"1181","article-title":"Diffusion of high Molecular weight compounds through sclera","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest. Ophthalmol. vis. Sci."},{"key":"10.1016\/j.ejpb.2024.114260_bib272","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fddev.2022.954771","article-title":"Topical ophthalmic administration: Can a drug instilled onto the ocular surface exert an effect at the back of the eye?","volume":"2","author":"del Amo","year":"2022","journal-title":"Front. Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114260_b0085","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11095-007-9408-z","article-title":"Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging","volume":"25","author":"Kim","year":"2008","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114260_b0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2010.08.028","article-title":"Barrier analysis of periocular drug delivery to the posterior segment","volume":"148","author":"Ranta","year":"2010","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ejpb.2024.114260_b0095","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.addr.2006.07.025","article-title":"Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling","volume":"58","author":"Ranta","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114260_b0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000266253","article-title":"Intraocular penetration kinetics of Prednisolone after subconjunctival injection in rabbits","volume":"20","author":"Tsuji","year":"1988","journal-title":"Ophthalmic Res."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114260_b0105","first-page":"297","article-title":"An autoradiographic study of the penetration of subconjunctivally injected Hydrocortisone into the Normal and inflamed rabbit eye","volume":"4","author":"McCartney","year":"1965","journal-title":"Invest. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114260_b0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/092739490500192","article-title":"A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation","volume":"12","author":"Gaudio","year":"2004","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejpb.2024.114260_b0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/OPTH.S223530","article-title":"Anesthesia for intravitreal injection: a systematic review","volume":"14","author":"Han","year":"2020","journal-title":"Clin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114260_b0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s40135-013-0029-x","article-title":"Antibiotics in pediatric Cataract surgery: subconjunctival versus Intracameral","volume":"1","author":"Trivedi","year":"2013","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.ejpb.2024.114260_b0125","first-page":"989501","article-title":"Intravitreal steroids for the treatment of retinal diseases","volume":"2014","author":"Sarao","year":"2014","journal-title":"TheScientificWorld"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114260_b0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3928\/1542-8877-19930701-06","article-title":"Intraocular dexamethasone penetration via subconjunctival or Retrobulbar injections in rabbits","volume":"24","author":"Bodker","year":"1993","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114260_b0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/jop.2007.0117","article-title":"Pharmacokinetic study of dexamethasone disodium phosphate using intravitreal, subconjunctival, and intravenous delivery routes in rabbits","volume":"24","author":"Hosseini","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114260_b0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9394(99)00129-4","article-title":"High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection","volume":"128","author":"Weijtens","year":"1999","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114260_b0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0378-5173(94)90194-5","article-title":"The effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-\u03b2-cyclodextrin formulations","volume":"104","author":"Loftsson","year":"1994","journal-title":"Int. J. Pharm."},{"issue":"Pt B","key":"10.1016\/j.ejpb.2024.114260_b0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal clearance and volume of distribution of compounds in rabbits: in silico prediction and pharmacokinetic simulations for drug development","volume":"95","author":"del Amo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114260_b0155","first-page":"105","article-title":"Dexamethasone metabolism by human liver in vitro. metabolite identification and inhibition of 6-hydroxylation","volume":"277","author":"Gentile","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2024.114260_b0160","doi-asserted-by":"crossref","first-page":"121361","DOI":"10.1016\/j.ijpharm.2021.121361","article-title":"Ocular metabolism and distribution of drugs in the rabbit eye: quantitative assessment after intracameral and intravitreal administrations","volume":"613","author":"del Amo","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114260_bib273","series-title":"Clinical pharmacokinetics and pharmacodynamics\u202f: concepts and applications","first-page":"839","author":"Rowland","year":"2011"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114260_b0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics14010012","article-title":"Pharmacokinetics of pullulan\u2013dexamethasone conjugates in retinal drug delivery","volume":"14","author":"Kickov\u00e1","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114260_b0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","volume":"341","author":"Nauck","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114260_b0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exer.2013.04.007","article-title":"Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: in vitro and in vivo evaluation. Preliminary results","volume":"112","author":"Giarmoukakis","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2024.114260_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.035","article-title":"Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment","volume":"214","author":"Voss","year":"2015","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114260_b0185","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1208\/s12249-017-0710-8","article-title":"PLGA Nanoparticles as subconjunctival injection for Management of Glaucoma","volume":"18","author":"Salama","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"21","key":"10.1016\/j.ejpb.2024.114260_b0190","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/adhm.201600780","article-title":"Long-term subconjunctival delivery of brimonidine Tartrate for glaucoma treatment using a Microspheres\/Carrier system","volume":"5","author":"Pek","year":"2016","journal-title":"Adv. Healthc. Mater."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114260_b0195","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/jop.2016.0042","article-title":"Sustained delivery of timolol maleate for over 90 days by subconjunctival injection","volume":"32","author":"Lavik","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2024.114260_b0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"\u201cImplications of melanin binding in ocular drug delivery\u201d, advanced drug delivery reviews","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114260_b0205","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1023\/B:PHAM.0000045231.51924.e8","article-title":"Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration","volume":"21","author":"Ayalasomayajula","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2024.114260_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108187","article-title":"Potential of subconjunctival aflibercept in treating choroidal neovascularization","volume":"199","author":"Nirmal","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114260_b0215","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000444327","article-title":"Ocular erythropoietin penetration after subconjunctival Administration in Glaucomatous Rats","volume":"56","author":"Resende","year":"2016","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejpb.2024.114260_b0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2021.06.003","article-title":"Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: tissue exposures in the rabbit eye","volume":"166","author":"Fayyaz","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114260_b0225","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1167\/iovs.07-0593","article-title":"Modeling of corneal and retinal Pharmacokinetics after Periocular drug administration","volume":"49","author":"Amrite","year":"2008","journal-title":"Invest. Ophthalmol. vis. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114260_b0230","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1167\/iovs.04-0091","article-title":"Controlled drug release from an Ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging","volume":"45","author":"Kim","year":"2004","journal-title":"Invest. Ophthalmol. vis. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114260_b0235","first-page":"187","article-title":"Pharmacokinetics and metabolism of 5-fluorouracil following subconjunctival versus intravenous administration","volume":"19","author":"Rootman","year":"1984","journal-title":"Can. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114260_b0240","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jps.2600690806","article-title":"Mechanisms of anterior segment absorption of pilocarpine following subconjunctival injection in albino rabbits","volume":"69","author":"Conrad","year":"1980","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114260_b0245","first-page":"509","article-title":"The difficulty of determining the route of intraocular penetration of gentamicin after subconjunctival injection in the rabbit","volume":"20","author":"Barza","year":"1981","journal-title":"Invest. Ophthalmol. vis. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114260_b0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1515\/jbcpp-2018-0002","article-title":"Rabbits and men: relating their ages","volume":"29","author":"Dutta","year":"2018","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114260_b0255","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1472-8206.1994.tb00822.x","article-title":"Comparative pharmacokinetics of two diastereoisomers dexamethasone and betamethasone in plasma and cerebrospinal fluid in rabbits","volume":"8","author":"Trenque","year":"1994","journal-title":"Fundam. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:06:49Z","timestamp":1713179209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":53,"alternative-id":["S0939641124000869"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114260","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive ocular and systemic pharmacokinetics of dexamethasone after subconjunctival and intravenous injections in rabbits","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114260"}}